Activation of the NF-κB and MAPK signal pathways were not affected by piperlongumine, and PI3K/AKT activation was low in most MM cells (MM1R and JJN3) without cytokine treatment (IGF) (Supplementary Figure S3). This evidence concerns the gene NFKB1 and Miyoshi myopathy.